NLRC5 gene expression highly correlated with HLA‐A, PSMB8, PSMB9, TAP1, and TAP2 genes of the MHC‐I pathway (r > 0.7; P < .0001, Figure 5A), and with CD8 and CD137 consistent with NLRC5 having a pivotal role in the activation of CD8 T‐cells within these tumours (r > 0.7; P < .0001, Figure 5B). The gene discussed is TNFRSF9; the disease is neoplasm.